Trial intelligence / Profile preview

Phase III trial of grazoprevir + elbasvir with or without ribavirin in prior peginterferon/ribavirin failures with chronic hepatitis C

NL-OMON40780Phase 3Active, not recruiting

Sponsor

Merck & Co.

Start

Jun 2014

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, DNA Intercalators/Alkylators → Nucleic Acid-Directed Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules

Countries

1